outcomes of all stratified by socioeconomic factors
Published 5 months ago • 52 plays • Length 3:40Download video MP4
Download video MP3
Similar videos
-
1:50
real-world outcomes of teclistamab treatment in r/r multiple myeloma
-
2:41
an overview of the latest advances in hematology
-
2:38
understanding science and research: the importance of patient advocates
-
0:55
a pooled analysis to determine the optimal ki-67 index cut-off point for predicting outcomes in mcl
-
1:32
factors contributing to the pathogenesis of icaht
-
30:38
correlation of multiplex immunofluorescence with rna sequencing | zhongmin xiang, phd | bostongene
-
46:06
[quality] q3a(r2)
-
6:42
analytical variation: imprecision and bias
-
1:12
using biomarkers and genomics to inform treatment strategy in all
-
3:17
pre-mds states: novel therapeutic approaches, and determining appropriate trial endpoints
-
1:27
occurrence & importance of endemic variants causing attrv in different regions of the world
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
0:47
overview of the phase iii enhance trial schema
-
2:42
optimizing biological agents for all
-
0:57
potential approval of quizartinib in aml & its place in the aml treatment regimen
-
1:20
exclusion criteria for allosct: numerical age and comorbidities should be considered together
-
2:27
factors affecting the accuracy of amyloidosis identification and referral to a specialty center
-
2:01
immunoprecipitation assay to identify target genes in leukemia | protocol preview
-
2:56
insights into the healthtree foundation
-
2:12
social media – a useful tool for hematological research
-
1:51
utilizing health resources